vs
Side-by-side financial comparison of IonQ, Inc. (IONQ) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IonQ, Inc. is the larger business by last-quarter revenue ($61.9M vs $47.7M, roughly 1.3× IRONWOOD PHARMACEUTICALS INC). IonQ, Inc. runs the higher net margin — 1217.8% vs -4.8%, a 1222.5% gap on every dollar of revenue. On growth, IonQ, Inc. posted the faster year-over-year revenue change (428.5% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $-83.3M).
IonQ, Inc. is an American quantum computing hardware and software company headquartered in College Park, Maryland. The company develops general-purpose trapped ion quantum computers and accompanying software to generate, optimize, and execute quantum circuits.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
IONQ vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.9M | $47.7M |
| Net Profit | $753.7M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | -369.4% | 14.3% |
| Net Margin | 1217.8% | -4.8% |
| Revenue YoY | 428.5% | -47.3% |
| Net Profit YoY | 473.1% | -200.9% |
| EPS (diluted) | $2.60 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.9M | $47.7M | ||
| Q3 25 | $39.9M | $122.1M | ||
| Q2 25 | $20.7M | $85.2M | ||
| Q1 25 | — | $41.1M | ||
| Q4 24 | $11.7M | $90.5M | ||
| Q3 24 | $12.4M | $91.6M | ||
| Q2 24 | $11.4M | $94.4M | ||
| Q1 24 | — | $74.9M |
| Q4 25 | $753.7M | $-2.3M | ||
| Q3 25 | $-1.1B | $40.1M | ||
| Q2 25 | $-176.8M | $23.6M | ||
| Q1 25 | — | $-37.4M | ||
| Q4 24 | $-202.0M | $2.3M | ||
| Q3 24 | $-52.5M | $3.6M | ||
| Q2 24 | $-37.6M | $-860.0K | ||
| Q1 24 | — | $-4.2M |
| Q4 25 | -369.4% | 14.3% | ||
| Q3 25 | -423.5% | 61.8% | ||
| Q2 25 | -776.0% | 53.2% | ||
| Q1 25 | — | -70.7% | ||
| Q4 24 | -661.9% | 34.8% | ||
| Q3 24 | -428.5% | 28.0% | ||
| Q2 24 | -430.0% | 26.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | 1217.8% | -4.8% | ||
| Q3 25 | -2646.3% | 32.8% | ||
| Q2 25 | -854.5% | 27.7% | ||
| Q1 25 | — | -90.9% | ||
| Q4 24 | -1725.0% | 2.5% | ||
| Q3 24 | -423.4% | 4.0% | ||
| Q2 24 | -330.0% | -0.9% | ||
| Q1 24 | — | -5.6% |
| Q4 25 | $2.60 | $0.01 | ||
| Q3 25 | $-3.58 | $0.23 | ||
| Q2 25 | $-0.70 | $0.14 | ||
| Q1 25 | — | $-0.23 | ||
| Q4 24 | $-0.95 | $0.03 | ||
| Q3 24 | $-0.24 | $0.02 | ||
| Q2 24 | $-0.18 | $-0.01 | ||
| Q1 24 | — | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.4B | $215.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.8B | $-261.8M |
| Total Assets | $6.6B | $396.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.4B | $215.5M | ||
| Q3 25 | $1.1B | $140.4M | ||
| Q2 25 | $546.9M | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | $340.3M | $88.6M | ||
| Q3 24 | $365.7M | $88.2M | ||
| Q2 24 | $369.8M | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $199.5M | ||
| Q2 25 | — | $199.3M | ||
| Q1 25 | — | $199.2M | ||
| Q4 24 | — | $199.0M | ||
| Q3 24 | — | $198.8M | ||
| Q2 24 | — | $198.6M | ||
| Q1 24 | — | $398.3M |
| Q4 25 | $3.8B | $-261.8M | ||
| Q3 25 | $2.3B | $-264.2M | ||
| Q2 25 | $1.2B | $-308.2M | ||
| Q1 25 | — | $-334.1M | ||
| Q4 24 | $383.9M | $-301.3M | ||
| Q3 24 | $435.7M | $-311.3M | ||
| Q2 24 | $463.3M | $-321.7M | ||
| Q1 24 | — | $-330.5M |
| Q4 25 | $6.6B | $396.9M | ||
| Q3 25 | $4.3B | $396.1M | ||
| Q2 25 | $1.3B | $342.9M | ||
| Q1 25 | — | $327.2M | ||
| Q4 24 | $508.4M | $350.9M | ||
| Q3 24 | $497.9M | $389.5M | ||
| Q2 24 | $517.4M | $395.6M | ||
| Q1 24 | — | $438.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-74.5M | $74.6M |
| Free Cash FlowOCF − Capex | $-83.3M | $74.6M |
| FCF MarginFCF / Revenue | -134.6% | 156.3% |
| Capex IntensityCapex / Revenue | 14.2% | 0.0% |
| Cash ConversionOCF / Net Profit | -0.10× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-307.3M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-74.5M | $74.6M | ||
| Q3 25 | $-123.1M | $47.6M | ||
| Q2 25 | $-52.6M | $-15.1M | ||
| Q1 25 | — | $20.0M | ||
| Q4 24 | $-39.4M | $15.2M | ||
| Q3 24 | $-19.2M | $9.9M | ||
| Q2 24 | $-26.6M | $33.5M | ||
| Q1 24 | — | $45.0M |
| Q4 25 | $-83.3M | $74.6M | ||
| Q3 25 | $-127.2M | $47.6M | ||
| Q2 25 | $-53.8M | $-15.1M | ||
| Q1 25 | — | $19.9M | ||
| Q4 24 | $-43.0M | — | ||
| Q3 24 | $-23.0M | $9.9M | ||
| Q2 24 | $-34.1M | $33.4M | ||
| Q1 24 | — | $44.9M |
| Q4 25 | -134.6% | 156.3% | ||
| Q3 25 | -319.1% | 39.0% | ||
| Q2 25 | -259.8% | -17.7% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | -367.4% | — | ||
| Q3 24 | -185.3% | 10.8% | ||
| Q2 24 | -299.3% | 35.4% | ||
| Q1 24 | — | 60.0% |
| Q4 25 | 14.2% | 0.0% | ||
| Q3 25 | 10.4% | 0.0% | ||
| Q2 25 | 5.8% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 30.7% | 0.0% | ||
| Q3 24 | 30.4% | 0.0% | ||
| Q2 24 | 65.8% | 0.1% | ||
| Q1 24 | — | 0.1% |
| Q4 25 | -0.10× | — | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | -0.64× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 6.74× | ||
| Q3 24 | — | 2.71× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IONQ
| Other | $31.2M | 50% |
| Platform Consulting And Support Services | $30.7M | 50% |
IRWD
Segment breakdown not available.
